IRIS - Res&Arch Institutional Research Information System - Research & Archive

IORIO, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.319
EU - Europa 9.528
AS - Asia 8.772
SA - Sud America 1.801
Continente sconosciuto - Info sul continente non disponibili 715
AF - Africa 220
OC - Oceania 25
Totale 34.380
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.724
SG - Singapore 4.124
IE - Irlanda 1.755
UA - Ucraina 1.699
RU - Federazione Russa 1.547
BR - Brasile 1.383
HK - Hong Kong 1.332
IT - Italia 1.055
CN - Cina 997
SE - Svezia 848
VN - Vietnam 840
DE - Germania 612
FR - Francia 562
FI - Finlandia 546
CA - Canada 414
GB - Regno Unito 372
KR - Corea 268
TR - Turchia 191
IN - India 190
BD - Bangladesh 148
AR - Argentina 127
IQ - Iraq 99
PL - Polonia 84
UZ - Uzbekistan 83
MX - Messico 80
CO - Colombia 75
EC - Ecuador 73
CH - Svizzera 70
AT - Austria 67
ID - Indonesia 60
NL - Olanda 60
PK - Pakistan 59
ZA - Sudafrica 56
SA - Arabia Saudita 54
JP - Giappone 52
PH - Filippine 44
VE - Venezuela 39
ES - Italia 37
LB - Libano 34
CZ - Repubblica Ceca 32
PY - Paraguay 31
BE - Belgio 30
RO - Romania 30
CL - Cile 27
GR - Grecia 27
MA - Marocco 26
MY - Malesia 26
TN - Tunisia 26
KE - Kenya 23
AE - Emirati Arabi Uniti 22
PE - Perù 22
LT - Lituania 21
PT - Portogallo 21
EG - Egitto 20
JO - Giordania 19
NP - Nepal 19
CR - Costa Rica 18
AU - Australia 17
DZ - Algeria 15
JM - Giamaica 15
EU - Europa 14
DO - Repubblica Dominicana 13
UY - Uruguay 13
BG - Bulgaria 12
HN - Honduras 12
KZ - Kazakistan 12
OM - Oman 12
AM - Armenia 11
BO - Bolivia 10
ET - Etiopia 10
TT - Trinidad e Tobago 9
NI - Nicaragua 8
PA - Panama 8
SN - Senegal 8
TW - Taiwan 8
BH - Bahrain 7
IL - Israele 7
NZ - Nuova Zelanda 6
SY - Repubblica araba siriana 6
AZ - Azerbaigian 5
KG - Kirghizistan 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
BF - Burkina Faso 4
DK - Danimarca 4
GE - Georgia 4
HU - Ungheria 4
LU - Lussemburgo 4
PR - Porto Rico 4
RS - Serbia 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CY - Cipro 3
GA - Gabon 3
GH - Ghana 3
GT - Guatemala 3
MN - Mongolia 3
NG - Nigeria 3
NO - Norvegia 3
Totale 33.611
Salva come PNG Salva come JPEG
Città #
Singapore 2.742
Dublin 1.753
Chandler 1.677
Hong Kong 1.323
San Mateo 1.097
San Jose 952
Jacksonville 762
Boardman 653
Ashburn 604
Santa Clara 545
Medford 485
Princeton 482
Dong Ket 477
Moscow 466
Lauterbourg 423
Wilmington 363
Altamura 355
Andover 343
Lawrence 280
Perugia 274
Seoul 264
Ottawa 262
Ann Arbor 241
Beijing 169
New York 168
Los Angeles 157
Ho Chi Minh City 144
Des Moines 139
São Paulo 138
Saint Petersburg 130
Piscataway 122
The Dalles 110
Norwalk 108
Izmir 106
Helsinki 93
Shanghai 88
Munich 84
Dallas 72
Columbus 67
Hanoi 66
Rio de Janeiro 57
San Paolo di Civitate 54
Falls Church 51
Chicago 49
Warsaw 47
Brooklyn 46
Orem 46
Phoenix 46
Montreal 45
Baghdad 42
London 42
Tokyo 42
Milan 40
Woodbridge 38
Frankfurt am Main 37
Chennai 35
Tashkent 35
Nuremberg 34
Rome 34
Brasília 33
Turku 33
Belo Horizonte 32
Bogotá 31
Houston 31
Johannesburg 31
Redwood City 31
Brussels 28
San Diego 27
Amelia 25
Denver 25
Stockholm 25
Atlanta 24
Buffalo 24
Guangzhou 24
Quito 24
San Francisco 24
Amsterdam 22
Dearborn 22
Salvador 22
Boston 21
Bucharest 21
Goiânia 21
Guayaquil 21
Istanbul 21
Jeddah 21
Lahore 21
Redmond 21
Council Bluffs 20
Curitiba 20
Manchester 20
Mexico City 20
Ankara 19
Den Haag 19
Nairobi 19
Ribeirão Preto 19
Auburn Hills 18
Frankfurt Am Main 18
Toronto 18
Amman 17
Dhaka 17
Totale 20.554
Salva come PNG Salva come JPEG
Nome #
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 190
1286 Prospective consecutive cases of venous thromboembolic diseases at the single Venous thromboembolic Unit of Reggio Emilia 164
Interventions for enhancing medication adherence. 163
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 162
Oral anticoagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS) 156
Establishing the prevalence and prevalence at birth of hemophilia in males a meta-analytic approach using national registries 136
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial 134
Serine base exchange enzyme in commercially available porcine lyophilised platelets: different effect of unfractionated and low molecular weight heparins 133
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 132
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 131
. The role of thrombophilic states in the bleeding tendency of patients with hemophilia 129
Development and validation of the first treatment satisfaction scale for adult haemophiliacs (Hemo0-SatA) 129
Influenza vaccination in patients on long-term anticoagulant therapy 125
Influenza vaccination in patients on long-term anticoagulant therapy. 124
A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation 122
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 120
Sindrome da anticorpi fosfolipidi. Descrizione di un caso clinico con trombosi atriale dx e revisione della casistica di Reggio Emilia 119
A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol. 117
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial 115
Audit clinico sull’impiego di plasma fresco congelato (PFC) in Umbria: disegno dello studio e risultati preliminari. 113
A Predictive Model for the Development of High-Responding Inhibitor In Children with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study. 113
Sustained suppression of hepatitics C by pegylated Interferon (PEG-INF) and Ribavirin in hemophilic patients 112
Systematic Review of Randomized Controlled Trials of Prophilactic Clotting Factor Concentrate in Hemophilia 112
Thrombophilia and cerebral vein thrombosis 112
Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase. 112
LMWH or Ximelagatran versus VKA in the prevention of VTE after major knee surgery: a meta-analysis of randomized controlled trials 111
Answering relevant research questions via careful observation of clinical practice: a fresh look at the old way forward. 111
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors. 110
L’organizzazione del centro per il monitoraggio della terapia anticoagulante orale 109
Low-molecular-weight-heparin for the long term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulant 109
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism 109
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results. 109
ACP Journal Club. A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis. 108
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. 108
Le trombofilie acquisite 107
Prothrombin 202120A mutation in Behcet’s disease 106
I disordini congeniti ed acquisiti dell’emostasi e della fibrinolisi 105
Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study. 105
D-DIMER TO PREDICT THROMBOSIS RECURRENCE: COMPARISON OF AGGREGATE DATA AND INDIVIDUAL PATIENT DATA META-ANALYSES. 105
Effect of dermatan sulphate on activated partial thromboplastin time determined with different reagents 104
Low-molecular-weight heparin treatment and cancer: pooled analysis of 908 patients treated for three months 103
Il monitoraggio della terapia anticoagulante orale 103
Defective indoleamine 2,3-dioxygenase induction is associated with inhibitor development in severe hemophilia a patients carrying f8 gene null mutations. 103
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls 103
Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen 103
Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project 102
The good use of plasma. A critical analysis of five international guidelines. 101
D-DIMER TO PREDICT THROMBOSIS RECURRENCE AFTER UNPROVOKED VENOUS THROMBOEMBOLISM: EFFECT OF PATIENT- AND D-DIMER-RELATED FACTORS ON RECURRENCE PREDICTION 101
D-DIMER TO PREDICT RECURRENCE AFTER A FIRST EPISODE OF UNPROVOKED VENOUS THROMBOEMBOLISM: COMPARISON OF AGGREGATE AND INDIVIDUAL PATIENT DATA META-ANALYSIS 101
A comparison of methods for prediction of pharmacokinetics across factor concentrate switching in hemophilia patients 101
Venous thromboembolic disease: clinical reatures of 1282 prospective consecutive cases at angiology unit of Reggio Emilia 100
Studio GEMINA: ruolo dei polimorfismi genetici e dell'omocisteinemia nell'infarto del miocardico in giovani-adulti italiani 100
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders. 100
GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks 100
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 99
Bayesian approach to the assessment of the population-specific risk of inhibitors in hemophilia A patients: a case study 99
Profilassi della trombosi venosa profonda in neurochirurgia 98
IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY 98
Experimental evidences on the role of silica nanoparticles surface morphology on the loading, release and activity of three proteins 98
APTT evaluation in the presurgery screening: survey of 5000 patients 97
Elderly patients treated with oral anticoagulant: a prospective cohort study 97
Ecaps study: multicentric evaluation of cerebral hemorrhage in anticoagulated/antiaggregated patients in the italian emergency rooms 97
Eradicazione del virus C dell'epatite (HCV) dopo terapia combinata con Interferone Pegilato (PEG-INF) e Rivabirina in pazienti emofilici HIV negativi 97
Low molecular weight heparin for prevention of venous thromboembolism in elective neurosurgery: a metanalysis 96
Risk factors for venous thromboembolism in patients undergoing elective neurosurgery 96
Impairment of fibrynolytic capacity in experimentally induced ketoacidosis in continuous subcutaneous insulin infusion patients 96
Prolonged antithrombin activity of low-molecular-weight heparins. Clinical implications for the treatment of thromboembolic diseases 96
A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease 96
Terapia anticoagulante orale con l’impiego di tecnologia POC e monitoraggio via web nell’ambito del Sistema Sanitario Nazionale Italiano 95
ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS 95
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis. 95
Different mechanism regulate phosphatidylserine synthesis in rat cerebral cortex" 95
Critical appraisal of five international guidelines on fresh frozen plasma clinical use. 95
Genima study: genetic polymorphysms and myocardial infarction among italian young adults 94
ACP Journal Club. The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care. 94
Clinical audit of the use of fresh frozen plasma in Umbria: study design and results of the pilot phase. 94
A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews 94
Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A 94
The association between platelet transfusions and mortality in patients with critical illness 94
Clinical and laboratoristic performance evaluation of three point-of-care devices for INR determination (Coagucheck, ProTime, Harmony) 93
D-Dimer Testing to Determine the Duration of Anticoagulation Therapy 93
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome 93
Gemina study:genetic polymorphysms and myocardial infarction among italian young adults 92
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 92
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C 92
RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS 92
Bioequivalence of B-domain deleted and plasma derived FVIII concentrates. 92
Thrombotic risk and laboratory pattern in 91 consecutive patients with lupus anticoagulant and/or anticardiolipin antibodies 91
Low-molecular-weight-heparin treatment and cancer: pooled analysis of 908 patients treated for three months and review of the literature 91
Hyperhomcysteinemia and other thrombophilic factors in Italian patients with inflammatory bowel disease 91
Objectives and methodology: Guidelines of the ItalianSociety for Haemostasis and Thrombosis (SISET). 91
Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interest 91
Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis 90
Heparin reduces venous thromboembolism in neurosurgery but increases the risk of bleeding. (Iorio A, Agnelli G. Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a metanalysis. Arch Intern Med. 2000;160:2327-2332) 90
HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY 90
Prospective assessment of clinical endpoints of vka treatment in a primary care computer assisted management model. 90
The association between venous thromboembolism and physical inactivity in everyday life 90
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 90
ANTITHROMBOTIC PROPHYLAXIS IN ELDERLY PATIENTS ATRIAL FIBRILLATION ADMITTED TO INTERNAL MEDICINE WARDS IN ITALY: ADHERENCE TO GUIDELINES 90
Pharmacoeconomic evaluation of the management of oral anticoagulant treatment with point-of-care devices in the Italian national health care system 89
Totale 10.624
Salva come PNG Salva come JPEG
Categoria #
all - tutte 171.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 171.746
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.921 0 0 92 136 120 35 63 1.364 34 23 442 612
2022/20235.866 537 876 94 412 467 654 8 301 2.238 10 192 77
2023/20242.072 156 226 107 36 36 14 507 125 209 81 237 338
2024/20255.028 19 617 63 140 707 102 88 417 1.134 343 998 400
2025/202610.205 779 566 625 1.420 1.011 1.034 1.951 578 1.020 897 240 84
2026/2027739 170 295 274 0 0 0 0 0 0 0 0 0
Totale 34.380